Structured Exercise After Cancer Tied to Lower Recurrence Risk
By @sharedot · · 7 pages
- Fitness
- Cancer Recovery
- Exercise Science
A pooled analysis of 21 randomized trials found structured exercise after cancer treatment linked to a 17% lower recurrence risk and longer survival.
What the analysis found
A study published in September in the *British Journal of Sports Medicine* pooled 21 randomized controlled trials involving 8,449 participants, most commonly covering breast, colorectal, and pancreatic cancer.
According to Medical News Today, participants who followed structured exercise were 17% more likely to live without cancer recurrence and had a 26% lower risk of dying from cancer.
Yahoo Health's write-up of the same pooled analysis reports the relative difference in mortality at about 23% — the two outlets' figures differ, so both are attributed here rather than averaged. The benefit is framed as added to treatment, not a replacement for it.
Why the result is surprising
Exercise after cancer is usually promoted for rebuilding strength, easing fatigue and improving quality of life.
Yahoo Health notes the stakes here look higher: because the underlying trials were randomized, the evidence is stronger than studies that simply compare people who choose to exercise with those who do not.
The design makes it plausible that movement is a legitimate component of survivorship care rather than an optional extra.
Medical News Today adds that people with high adherence — 70% or more of the prescribed plan — were more likely to experience greater benefits, and that benefits appeared more pronounced in people with early-stage cancer.
Does the type of exercise matter?
According to Medical News Today, aerobic exercise alone was associated with a 29% lower relative risk of death, while combining aerobic work with resistance training showed roughly a 25% lower relative risk; resistance training alone did not reach statistical significance.
Texas Oncology oncologist Mike Lattanzi, speaking to Medical News Today, said exercise might impair cancer cell metabolism and enhance the efficacy of antitumor immune cells.
Physical therapist Diana Garrett told the same outlet that physical activity acts as a systemic intervention across the cardiovascular and immune systems, and that regular exercise has been shown to increase immune activity — which may be especially important for patients with a cancer history.
Safety and individualized plans
Both outlets stress that survivors should not copy a generic workout.
Garrett told Medical News Today that safety considerations must be set on an individual basis, factoring in prior activity level, treatment received, lingering toxicities, cardiovascular health and physical impairments — noting some chemotherapy drugs affect the heart, so intensity may need modification.
Yahoo Health adds that anemia, neuropathy, bone weakness and fatigue can all change what is appropriate, and that someone with bone metastases needs very different guidance from someone past early-stage treatment.
The recommendation is to coordinate with oncologists, primary care physicians or cardiologists and baseline-test fitness and strength before building a program.
What comes next
Yahoo Health cautions that these are relative risk estimates across diverse trials, not a promise of the same benefit for every cancer or patient, and that cancer type, stage, treatment and baseline fitness all matter.
The research does not make exercise a cancer drug, and it does not erase the need for surgery, radiation, chemotherapy or immunotherapy. Medical News Today's experts frame the practical takeaway as working with a cancer care team to set target heart rates and modifications.
Notably, the same week's evidence base extends beyond cancer: a *BMJ* analysis of 124 trials covered by Women's Health found brisk walking and jogging the most effective exercise for bone mineral density, at roughly two to three hours a week.